Vilket är priset för Infinity Pharmaceuticals, Inc. (INFI)

Priset för Infinity Pharmaceuticals, Inc. (INFI) är $0.0039

Vilket är marknadsvärdet för Infinity Pharmaceuticals, Inc. (INFI)

Marknadsvärdet för Infinity Pharmaceuticals, Inc. (INFI) är $235.97K

Infinity Pharmaceuticals, Inc. (INFI) Utestående Aktier

Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge, Massachusetts, operates as a biopharmaceutical firm dedicated to creating innovative therapies for individuals battling cancer. A central component of its pipeline is IPI-549, an experimental immuno-oncology drug taken orally. This candidate, currently in clinical development, functions by blocking the phosphoinositide-3-kinase-gamma enzyme. IPI-549 is undergoing Phase 2 trials for metastatic triple negative breast cancer and urothelial cancer, and Phase 1/1b trials for various solid tumors. The company maintains several strategic partnerships: with Intellikine, Inc. for the discovery, development, and commercialization of PI3K delta and/or gamma isoform-targeting pharmaceuticals; with Verastem, Inc. for the research, development, commercialization, and production of duvelisib and related compounds; and with PellePharm, Inc. to advance and commercialize its hedgehog inhibitor program, IPI-926, which is also a clinical-stage investigational drug. Furthermore, Infinity Pharmaceuticals holds collaborative agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company.

År	Utestående aktier	Ändra
Inte tillräckligt med data för de angivna datumen.

År

Utestående aktier

Ändra

Inte tillräckligt med data för de angivna datumen.

Företag	Utestående aktier	Skillnad	Land
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	0.00	-	BE

Företag

Utestående aktier

Skillnad

Land